Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
K. Wyatt Engwall currently holds 209,550 shares of THERAGENICS CORP (TGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, K. Wyatt Engwall has been a net buyer of TGX stock. They have purchased $200.0K and sold $0 worth of shares.
K. Wyatt Engwall's most recent insider trade was on Oct 29, 2013, when they sold 209,550 shares at $2.20 per share.
K. Wyatt Engwall serves as Executive at THERAGENICS CORP (TGX). They have executed 14 insider transactions totaling $200.0K over their tenure at the company.
K. Wyatt Engwall holds the position of Executive at THERAGENICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
K. Wyatt Engwall has shown a buying trading pattern, with $200.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by K. Wyatt Engwall was on Oct 29, 2013, when they sold $461.0K worth of TGX shares. This transaction involved 209,550 shares at $2.20 per share.
K. Wyatt Engwall currently owns 209,550 shares of THERAGENICS CORP (TGX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of K. Wyatt Engwall's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. K. Wyatt Engwall has 14 Form 4 filings on record as an insider at THERAGENICS CORP.
Set alerts for K. Wyatt Engwall and 40,000+ other insiders.